Risk factors for recurrent retinal detachment

To determine the risk factors associated with recurrent retinal detachment in patients vitrectomized. Case-control study nested in a cohort. We included patients with a diagnosis of rhegmatogenous retinal detachment treated with vitrectomy for one year, with a six months follow-up. We monitored the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Revista médica (Mexico : 1983) 2014-01, Vol.52 (1), p.34
Hauptverfasser: Sánchez-Ramos, Jorge Arturo, Blanco-D'Mendieta, Lizbeth Karina, Soto-Hernández, María de Lourdes, Márquez-González, Horacio, Sepúlveda-Vildósola, Ana Carolina
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To determine the risk factors associated with recurrent retinal detachment in patients vitrectomized. Case-control study nested in a cohort. We included patients with a diagnosis of rhegmatogenous retinal detachment treated with vitrectomy for one year, with a six months follow-up. We monitored the presence of incident event in the emergency department, and the examination room. Statistical analysis was performed by descriptive statistics (median, minimum and maximum) and inferential statistics (chi-squared test, Cox regression, Kaplan-Meier). A population of 94 patients with a median age of 55 years (21-83) was analyzed. The silicone was the most widely used type of tamponade in 62 patients (66 %) and recurrent retinal detachment occurred in 19 cases (20 %). In the relation between the non-relapse group and the relapse group, the statistically significant variable was the use of silicone (p = 0.05, OR = 0.03, 0.013-0.98), wich had a lower probability of recurrent detachment compared with the use of sulfur hexafluoride (SF6 gas) (p = 0.012). The use of silicone compared with the use of SF6 gas has shown to be a protective factor for recurrent retinal detachment; however, the choice of method of tamponade should be individualized for each patient.
ISSN:0443-5117